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The adenovirus (Ad) early transcription unit 3 (E3) encodes multiple immunosubversive functions that are
presumed to facilitate the establishment and persistence of infection. Indeed, the capacity of E3/19K to inhibit
transport of HLA class I (HLA-I) to the cell surface, thereby preventing peptide presentation to CD8 T cells, has
long been recognized as a paradigm for viral immune evasion. However, HLA-I downregulation has the potential to
render Ad-infected cells vulnerable to natural killer (NK) cell recognition. Furthermore, expression of the imme-
diate-early Ad gene E1A is associated with efficient induction of ligands for the key NK cell-activating receptor
NKG2D. Here we show that while infection with wild-type Ad enhances synthesis of the NKG2D ligands, major
histocompatibility complex class I chain-related proteins A and B (MICA and MICB), their expression on the cell
surface is actively suppressed. Both MICA and MICB are retained within the endoplasmic reticulum as immature
endoglycosidase H-sensitive forms. By analyzing a range of cell lines and viruses carrying mutated versions of the
E3 gene region, E3/19K was identified as the gene responsible for this activity. The structural requirements within
E3/19K necessary to sequester MICA/B and HLA-I are similar. In functional assays, deletion of E3/19K rendered
Ad-infected cells more sensitive to NK cell recognition. We report the first NK evasion function in the Adenoviridae
and describe a novel function for E3/19K. Thus, E3/19K has a dual function: inhibition of T-cell recognition and NK
cell activation.
The Adenoviridae family includes clinically important viruses
associated with acute episodes of pharyngitis, conjunctivitis, diar-
rhea, and cystitis in immunocompetent individuals. In immuno-
suppressed patients, particularly pediatric transplant recipients,
adenoviruses (Ads) are capable of systemic viremic spread that
produces significant levels of morbidity and mortality. More than
50 human Ads have been described, of which the common species
C serotypes 2 and 5 (HAdV-2 and HAdV-5) have been studied
most intensively (52), and demonstrated to encode functions that
act in vitro and in vivo to promote evasion of both innate and
adaptive host immune responses (11). Immunomodulatory func-
tions are concentrated in the early transcription unit E3 (33, 51).
An E3 protein, E3/19K, became an immunological paradigm
when it was demonstrated to impede cell surface antigen presen-
tation by retaining the major histocompatibility class I complex
(MHC-I) in the endoplasmic reticulum (ER) (1, 8, 10, 17). E3/
10.4K and E3/14.5K (the RID complex) together remove Fas,
tumor necrosis factor-related apoptosis-inducing ligand receptors
1 and 2, and the epidermal growth factor receptor from the cell
surface and promote their subsequent degradation in lysosomes
(5, 12, 18, 24, 44, 45, 51). Moreover, E3/14.7K suppresses inflam-
mation and cytolysis by inhibiting tumor necrosis factor alpha-
mediated signaling independently of the RID complex (11, 26).
We are interested in the role of NK cells in controlling Ad
infections. NK cells are a heterogeneous population of cells
expressing a wide range of activating and inhibitory receptors.
NKG2D is a homodimeric activating receptor that is ubiqui-
tously expressed on NK cells,  T cells, and NKT cells and
also on certain  T-cell subsets (3). To date, seven human
cellular NKG2D ligands (NKG2DLs) have been identified: the
MHC-I chain-related A (MICA) and B (MICB) proteins, the
UL16 binding proteins ULBP1 to -3, and the retinoic acid early
inducible proteins E (ULBP4) and G (2, 3, 16). While MICA
and MICB are closely related, sharing 84% amino acid (aa)
identity and similar tertiary structures (25, 32), they are also
highly polymorphic, with 61 MICA and 30 MICB alleles having
been described (IMGT; http://imgt.cines.fr/). The induction of
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NKG2DLs has been reported to occur in response to stress,
including infection, genotoxic stimuli, cell transformation, and
heat shock (22, 23). Crucially, HAdV-5 E1A has been demon-
strated to upregulate NKG2DLs in both transformed human
and rodent cell lines (15, 39), rendering them susceptible to NK
cell attack. More recently, we have shown that breakthrough
expression from replication-deficient HAdV-5 E1-negative vec-
tors also upregulated NKG2DLs and thereby sensitized vector-
transduced cells to NK attack (48). Ad thus encodes E1-depen-
dent and E1-independent functions that act separately to
stimulate NKG2DL expression.
The efficient upregulation of NKG2DLs combined with the
simultaneous intracellular retention of endogenous MHC-I
theoretically should render Ad-infected cells extremely vulner-
able to NK cell attack. We therefore sought to investigate the
impact of NKG2DL activation during productive Ad infection.
Unexpectedly, cell surface expression of MICA and MICB was
efficiently suppressed during wild-type (wt) HAdV-5 infection.
Ad was shown to encode a function that acts posttranslation-
ally to sequester both MICA and MICB within the ER. This is
the first description of an Ad NK cell evasion function and
provides novel insights into the role of E3/19K as a potential
virulence factor.
MATERIALS AND METHODS
Cells. Human fetal foreskin fibroblasts (HFFF), HFFF immortalized with
human telomerase reverse transcriptase (37) and transduced with a retrovirus
expressing the human coxsackievirus Ad receptor (31) (HFFF-hTERT-hCAR),
human embryonic retinoblast 911 cells, and human embryonic kidney 293 cells
were all grown in Dulbecco modified Eagle medium supplemented with 10%
fetal calf serum (Invitrogen). HFFF-hTERT-hCAR were used in all experiments
using fibroblasts except those shown in Fig. 1A and are referred to as HF
throughout. The 911 MICA-YFP cell line was generated by transfection with a
MICA-yellow fluorescent protein (YFP) fusion construct (a kind gift from
Daniel Davis, Imperial College, London) (36) and selection with G418 (0.75
mg/ml). The 293 cell lines, E3-45 and E22.7, were established following trans-
fection with the EcoRV C and EcoRI D fragments of HAdV-2, containing all or
a part of the E3 region, respectively (30). All E3/19K mutants have been gen-
erated in the EcoRI D fragment, which was then transfected into 293 cells
together with the neophosphotransferase gene. After selection, 293 transfectants
were routinely cultured in Dulbecco modified Eagle medium–10% fetal calf
serum containing 200 g/ml G418. Substituting alanine for the conserved tryp-
tophan in position 96 of HAdV-2 E3/19K created mutant W96A. Transfectants
were selected on the basis that they expressed a similar amount of E3/19K as
detected by a rabbit antiserum against the cytoplasmic tail of E3/19K (40) or
additional monoclonal antibodies (MAbs) (B. Menz and H.-G. Burgert, unpub-
lished). EKE*1 cells express a modified E3/19K molecule with the transmem-
brane segment replaced by that of MHC-I and the lysines of the ER retrieval
signal altered to serines (KKMP3SSMP). This E3/19K mutant is efficiently
transported to the cell surface. The cysteine mutants have been described pre-
viously (40).
FIG. 1. Ad carries an E3 gene that downregulates cell surface MICA/B. (A) HFFF infected at a multiplicity of infection of 50 with a
replication-deficient (E1,E3) HAdV-5 vector (RAd60) or wt HAdV-5 were stained at 48 h p.i. with an anti-MICA/B antibody or control IgG and
analyzed by flow cytometry. The mouse IgG control is shown by the thin line, and the filled histograms represent staining with anti-MICA/B. The
mean fluorescence intensity of MICA/B staining of mock-, RAd60-, or HAdV-5-infected cells is depicted in the top right corner of the histogram.
(B) E3 genes present in each of the three viruses. (C) 911 cells infected at a multiplicity of infection of 5 with wt HAdV-5, RAd60, or RAd592
were stained at 24 h p.i. with anti-MICA/B antibody or control IgG before analysis by flow cytometry. The mouse IgG control is shown by the thin
line, staining of mock-infected cells is in gray fill, and staining of infected cells is represented by the bold line. The mean fluorescence intensity of
MICA/B staining of HAdV-5-, RAd60-, or RAd592-infected cells is depicted in the top right corner of the histogram.
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MICA genotyping. Genomic DNA was used to amplify a 2.2-kb fragment of
the MICA gene encompassing exons 2, 3, 4, and 5. Sequencing-based typing was
performed using primers to sequence exons 2, 3, and 4 in both orientations (29,
55). Sequence analysis and assignment of MICA allele type were performed
using AssignSBT (Connexio Genomics, Australia). Ambiguous types were ana-
lyzed further if distinguishable by the number of GCT repeats in exon 5 using a
reverse sequencing primer to sequence exon 5. The combination of GCT triplets
was identified by the heterozygous sequence as described previously (54).
Viruses. The generation of the Ad-Easy-1-based vector RAd592 (48) and the
pJM17-based vector RAd60 (50) has been described previously. Both of these
vectors are E1 deleted, and neither expresses a transgene. Ad-Easy-1-based
vectors have a deletion in the E3 region spanning bp 28130 to 30820 of the Ad5
genome, eliminating all E3 open reading frames (ORFs) except 12.5K, which is
present but incomplete and thus is likely to be nonfunctional. pJM17-based
vectors are based on the HAdV-5 dl309 virus, which has a deletion running from
bp 30005 to 30750 leading to partial or complete deletion of the 10.4K, 14.5K,
and 14.7K ORFs; hence, the protein products of these genes are not expressed
(6). wt HAdV-5 was provided by Vivien Mautner, University of Birmingham,
United Kingdom. wt Ad5 and the E3/19K mutants were grown and titers were
determined on A549 cells. The Ad5-based vectors RAd60 and RAd592 were
grown and titers were determined on 293 cells. A549 and 293 exhibit comparable
infectivities. Virus-infected cells were recovered by centrifugation and washed
with phosphate-buffered saline (PBS), and virus was extracted using Arklone P as
described previously (28).
To clone the HAdV-5 genome into a single-copy vector, Ad genomic DNA was
isolated from purified virions using the QIAamp blood kit (Qiagen). Purified
viral DNA was then cotransformed into induced SW102 bacteria (49) with
a modified bacterial artificial chromosome (BAC)-based vector based on
pBeloBAC11 (New England Biolabs) in which the left (bp 1 to 480) and right (bp
34951 to 35938) ends of the Ad5 genome had been cloned. The BAC construct
was linearized with NheI, which cuts between the arms of homology, to promote
homologous recombination. Chloramphenicol-resistant colonies were grown,
and BAC DNA was extracted and digested with the appropriate enzymes to
confirm the HAdV-5 genome had been successfully cloned. The generated con-
struct, pAL908, contains the wt HAdV-5 genome. pAL908 was used as a parental
construct to generate a number of E3/19K mutants using “recombineering.”
Recombineering was performed essentially as described previously (49), using a
selectable marker cassette that allows both positive and negative selection (sacB
lacZ Ampr). To modify the parental genome in the BAC vector, the selectable
marker was amplified using PCR primers (sequences are available on request)
that contain homology to the appropriate regions of the HAdV-5 genome to
target homologous recombination. Following successful recombination, the se-
lectable marker was then removed using single-stranded or double-stranded
DNA oligonucleotides containing the appropriate deletion, insertion, or substi-
tution. Prior to transfection, BAC DNA was extracted from a 500-ml overnight
culture using the BacMax 100 kit (Macherey-Nagel, Duren, Germany). BAC
DNA was digested with PacI, whose recognition sites flank the HAdV-5 inverted
terminal repeats in the BAC vector, and then transfected into 911 cells. Infec-
tious virus was isolated, digested, and sequenced to confirm the appropriate
genomic structure. The viruses generated contain the following mutations: E3/
19K (RAd918) has a 290-bp deletion beginning 56 bp into the E3/19K ORF,
E3/19KSTOP (RAd930) has a premature stop codon and frameshift inserted 33
bp into the ORF, and E3/19KW96A (RAd936) has a mutation that converts a
TGG(W) codon to a GCT(A) codon 339 bp into the ORF.
Flow cytometry and immunofluorescence. For flow cytometry analysis, a
FACSCalibur or FACscan with CELLQuest Pro software (Becton Dickinson)
was used. Staining was performed as previously described (18, 40). Before im-
munofluorescence, cells were fixed with paraformaldehyde and were perme-
abilized with 0.5% NP-40. Fluorescence was detected and analyzed with a Leica
DMIRBE microscope with Improvision Openlab software. The following mouse
MAbs were used: Tw1.3 against E3/19K (17), W6/32 against HLA-I (ATCC
HB95), HC10 against HLA-I (42), DX2 against Fas (Calbiochem), MAB3126
against calnexin (Chemicon International), 6D4 against MICA/B, AF1300 against
MICA/B (R&D), MAB1300 against MICA (R&D), 1599 against MICB (R&D),
2211S against phospho-S6-ribosomal protein (Cell Signaling), and M58M73
against Ad E1A (Abcam ab3648). Secondary antibodies included goat anti-
mouse immunoglobulin G (IgG) conjugated to AlexaFluor 594 (A-11020),
AlexaFluor 488 (A-11001), and AlexaFluor 647 (A-21237), all from Invitrogen.
NK cell CD107a mobilization assays. A total of 106 alpha interferon (IFN-
)-activated peripheral blood mononuclear cells (PBMC) were incubated for 6 h
with 2  105 HF (48 h postinfection [p.i.]) and anti-CD107a-FITC MAb (3 l for
106 PBMC; BD Biosciences), with 6 l/ml BDGolgiStop (BD Biosciences)
present for the last 5 h. PBMC were then harvested, washed in cold PBS, and
stained for 30 min at 4°C with anti-CD3-PerCP (clone SK7; BD Biosciences) and
anti-CD56-allophycocyanin (clone N901; Beckman Coulter) MAbs. Cells were
washed twice in cold PBS, and a minimum of 4  103 CD3	 CD56 NK cells
were acquired from each sample.
Protein analysis. Protein extracts were separated on 10% bis-Tris gels (In-
vitrogen) before Western blotting and incubation with an anti-MICA/B poly-
clonal antibody (R&D, AF1300) and donkey anti-goat IgG–horseradish perox-
idase (Santa Cruz, Sc-2056). Glycosylation was analyzed by digestion with
endoglycosidase (EndoH) or peptide-N-glycosidase F (PNGase F) according to
the manufacturer’s instructions (New England Biolabs).
RESULTS
Identification of an NK cell evasion function in the HAdV-5
E3 region. The effect of Ad infection on NKG2DL expression
was investigated first in primary HFFF. Consistent with previ-
ous observations (48), delivery of a replication-deficient
HAdV-5 E1,E3 vector clearly induced MICA/B surface ex-
pression (Fig. 1A). However, HFFF infected in parallel with wt
HAdV-5 did not exhibit an increase in surface MICA/B (Fig.
1A). This finding indicated that HAdV-5 may encode a func-
tion to control MICA/B during productive infection. Expres-
sion of viral genes from replication-deficient vectors in HFFF
is restricted by the E1 deletion. To complement this genetic
defect in replication-deficient vectors, the E1-positive 911
helper cell line was infected with two such vectors: RAd592
effectively lacks all E3 functions, whereas RAd60 has a partial
deletion (Fig. 1B). 911 cells constitutively express high levels of
surface MICA/B, which was efficiently downregulated follow-
ing infection with both RAd60 and wt HAdV-5 but not with
RAd592 (Fig. 1C). Since the function responsible for suppress-
ing MICA/B was retained in RAd60 yet was absent from
RAd592, it was provisionally mapped to E3 and more specif-
ically to the 12.5K, 6.7K, 19K, and/or 11.6K ORF (Fig. 1B).
Downregulation of MICA/B is mediated by E3/19K. A panel
of 293 cell lines containing the complete HAdV-2 E3 region
and targeted deletions therein was exploited to identify the
function responsible for suppression of MICA/B surface ex-
pression (Fig. 2A). Since HLA-I and Fas are recognized tar-
gets of E3/19K and E3/10.4-14.5K (RID), respectively, their
expression serves as a measure of E3 function and was deter-
mined alongside that of MICA/B. As expected, Fas surface
expression was downregulated only in E3-45 cells, as only these
cells express an intact RID (10.4K and 14.5K) complex (18).
Cell surface MICA/B and HLA-I were efficiently downregu-
lated in both the E3-45 and E22.7 cells; both cell clones express
unmodified versions of E3/19K. HAdV-2 E3/19K is a glyco-
protein comprising an N-terminal 
105-aa ER-luminal do-
main, a 
22-aa hydrophobic transmembrane sequence, and a
15-aa cytoplasmic tail (Fig. 2B). E3/19K has two functional
entities: the luminal part containing two disulfide bonds essen-
tial for binding HLA (40) and a C-terminal ER retrieval signal
mediating retrograde transport of E3/19K and associated HLA
from the cis-Golgi apparatus to the ER (27). In the EKE*1 cell
line, the C-terminal ER retrieval signal has been mutated and
the substitutions made in the transmembrane domain so that
the modified E3/19K escapes to the cell surface (51). Neither
HLA-I nor MICA/B was efficiently downregulated in the
EKE*1 cells. Thus, we conclude that E3/19K is responsible for
suppressing cell surface expression of MICA/B.
MICA and MICB are both cell surface glycoproteins with
MHC-I-like 1, 2, and 3 domains, yet neither associates
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with 2-microglobulin or presents peptide (23). While MICA
and MICB share 84% aa identity, they also exhibit 23 to 35%
identity with domains in classical MHC-I heavy chains (32).
Within the MHC-I heavy chain, the 1 and 2 domains appear
to be critical for E3/19K binding (4, 9, 19, 20). To help identify
sequence elements within E3/19K responsible for MICA/B
suppression, a series of cysteine mutants of E3/19K were
tested. The E3/19K luminal domain contains two intramolec-
ular disulfide bonds between the conserved cysteines Cys11-
Cys28 and Cys22-Cys83, which are essential for binding
MHC-I, whereas the C-proximal cysteines 101, 109, and 122
are dispensable for this function (40) (Fig. 2B). A similar
requirement was observed for control of MICA/B; downregu-
lation was compromised when the four conserved N-proximal
cysteines (aa 11, 22, 28, and 83) were replaced by serines,
whereas mutation of the three C-proximal cysteines (aa 101,
109, and 122) had no significant effect (Fig. 2D). Some differ-
ences in the efficiency of downregulation of HLA and MICA/B
were observed (e.g., with the Cys101 mutant). Interestingly, a
point mutant with alanine substituted for tryptophan at posi-
tion 96 (W96A) was unable to efficiently downregulate HLA-I
surface expression in 293 cell lines yet substantially suppressed
cell surface expression of MICA/B (Fig. 2C).
Characterization of HAdV-5 E3/19K mutants. To evaluate
E3/19K function in the context of productive infection, specific
mutants were generated. The wt HAdV-5 genome was cloned
into a BAC, and the following E3/19K mutants generated using
DNA “recombineering”: (i) HAdV-5 E3/19K, incorporating
a deletion of aa 2 to 98; (ii) HAdV-5 E3/19KSTOP, with an
insertion of a premature termination codon and frameshift
after aa 11 in the signal sequence; and (iii) HAdV-5 E3/
19KW96A, with an alanine substitution for tryptophan 96 (Fig.
3A). Ablation of E3/19K expression in cells infected with
HAdV-5 E3/19K and HAdV-5 E3/19KSTOP was confirmed
by Western blotting (Fig. 3B). The point mutation in the E2-
W96A cell line, associated with downregulation of MICA/B
but not HLA-I (Fig. 2C), was essentially replicated in HAdV-5
E3/19KW96A; this modified protein was expressed in similar
abundance by the mutant virus (Fig. 3B).
MICA/B surface expression was profoundly upregulated in
HF (telomerase-immortalized human fibroblasts expressing
hCAR) infected with the HAdV-5 mutants E3/19K and E3/
19KSTOP relative to the wt parental virus or mock-infected
cells (Fig. 3C). Further analyses, using antibodies that could
differentiate between MICA and MICB in flow cytometry,
demonstrated comparable upregulation of MICA and MICB
following infection with both HAdV-5 E3/19K-negative viruses
that was not apparent with the parental wt virus. E3/19K-
specific downregulation of both MICA and MICB was also
observed in the continuous cell lines detailed in Fig. 2A when
resolving antibodies were used to monitor surface expression
(data not shown). The HAdV-5 E3/19KW96A mutant effec-
tively reproduced the findings obtained with the E2-W96A cell
line in that there was a substantial downregulation of MICA
and MICB surface expression whereas the prevention of
HLA-I maturation was less effective (see Fig. 4C). Most sig-
nificantly, productive Ad infection was demonstrated to stim-
ulate the efficient induction of NKG2DLs, with MICA and
MICB surface expression being prevented only by the action of
E3/19K.
E3/19K promotes evasion of NK recognition. The genera-
tion of HAdV-5 E3/19K mutants enabled the role of E3/19K in
modulating NK cell recognition to be evaluated in a functional
assay. The CD107a mobilization assay detects lysosome-asso-
ciated membrane protein-1 released to the surface of NK cells
following degranulation and therefore provides a direct read-
out of NK cell function. IFN--activated PBMC were incu-
bated (6 h) with HF infected with HAdV-5 and the various
E3/19K mutants (48 h p.i.), and NK cells (defined as CD3	
CD56) were assessed for CD107a expression by flow cytom-
etry. A representative result from three independent experi-
ments performed is depicted in Fig. 3D. Differences in CD107a
expression on NK cells following incubation with mock- and
Ad-infected cells were analyzed using the analysis of variance
test with Bonferroni’s posttest. This indicated that the 
2-fold
increase in CD107a expression following incubation with the
HAdV-5 E3/19K and E3/19KSTOP mutants compared to wt
infection was statistically significant (P  0.05 and P  0.01,
respectively). The difference in CD107a expression following
incubation with cells infected with wt virus or the W96A E3/
19K mutant was consistent but not statistically significant and
thus should not be given weight. Since MHC-I is known to be
a ligand for multiple NK cell inhibitory receptors, its down-
regulation by E3/19K may be expected to stimulate NK recog-
nition. However, only a modest activation was observed with
the wt HAdV-5 relative to mock-infected controls. In contrast,
functional inactivation of E3/19K by deletion or mutation re-
sulted in a marked stimulation of NK cell activation. Thus,
protection against NK cell recognition in the context of a
productive HAdV-5 infection is mediated by E3/19K expres-
sion.
FIG. 2. The Ad E3/19K glycoprotein inhibits surface expression of MICA/B. (A) Composition of the E3 region in the E3-45 cells, E22.7 cells,
and EKE*1, E2-C83S, and E2-W96A transfectants. (B) Schematic representation of the E3/19K structure, with the conserved cysteines numbered
and positions of N-linked glycosylation sites indicated with filled circles. E3/19K expressed by EKE*1 has a mutated cytoplasmic tail and a
substituted transmembrane region and reaches the cell surface efficiently (data not shown). E2-C83S and E2-W96A have the indicated amino acid
substitution in E3/19K. (C) 293 cell lines stably transfected with HAdV-2 E3 region constructs were stained for surface expression of HLA-I (black
fill), MICA/B (gray fill), and Fas (unfilled) and analyzed by flow cytometry. The bars denote the relative percentage of expression compared to
untransfected 293 cells, whose mean fluorescence intensity was set to 100%. Data were compiled from 5 independent experiments. Differences
in cell surface expression of Fas, MICA/B, and HLA in the various E3/19K mutant cell lines were analyzed using the analysis of variance test with
Bonferroni’s posttest. This showed that the actual level of reduction of MICA/B and HLA in EKE*1 was not significantly different (P  0.05).
However, in E2-W96A cells the reduction of MICA/B cell surface expression was significantly more pronounced (reduction by 58%) than the
downregulation of HLA (reduction by 22.1%) (P  0.001). (D) Expression of HLA (black fill) and MICA/B (gray fill) in stable 293 transfectants
expressing cysteine mutants of E3/19K (indicated by the number on the x axis) relative to untransfected cells and cells expressing wt E3/19K. Two
clones from each construct were analyzed in at least four independent experiments. The error bars represent standard errors.
VOL. 82, 2008 ADENOVIRUS DOWNREGULATION OF MICA/B 4589
 o
n
 February 25, 2014 by Cardiff Univ
http://jvi.asm.org/
D
ow
nloaded from
 
E3/19K promotes MICA/B retention in the ER. To investi-
gate the effect of E3/19K on posttranslational processing of
MICA/B, extracts were prepared from the panel of E3-express-
ing cell lines (detailed in Fig. 2A) and subjected to EndoH or
PNGase F treatment (Fig. 4A). EndoH will cleave only mole-
cules containing high-mannose sugars, whereas those having
acquired complex-type carbohydrates during the transport
through the medium/trans-Golgi apparatus become resistant.
Thus, EndoH resistance is indicative of MICA/B transport
through the medium/trans-Golgi apparatus. As a control, ex-
tracts were also treated with PNGase F, which cleaves all
N-linked carbohydrates. In the parental 293 cell line, MICA/B
was detected as a diffuse EndoH-resistant, 
60-kDa protein,
with two species (40 and 33 kDa) observed following PNGase
F digestion. 293 cells are homozygous for the truncated
MICA*008 allele that lacks a cytosolic domain. The apparent
molecular mass of the faster-migrating species (
33 kDa) de-
tected in Fig. 4A is consistent with it being the deglycosylated
form of MICA*008, predicted to be 35 kDa. In contrast, in
cells expressing wt E3/19K (E3-45 and E22.7) a lower-molec-
ular-mass EndoH-sensitive species of 
48 kDa was apparent,
indicating incomplete posttranslational processing of MICA/B.
MICA/B was resistant to EndoH digestion in cells expressing
the E3/19K mutants EKE*1 and C83S; both forms of E3/19K
were also impaired in suppressing MICA/B cell surface expres-
sion (Fig. 2C). In the W96A cell line, both the EndoH-sensitive
and EndoH-resistant forms were present, with the EndoH-
sensitive form predominating. This is consistent with this point
mutant possessing an intermediate phenotype.
To corroborate these results during virus infection, Western
blot experiments were also performed on extracts prepared
from virus-infected cells. HAdV-5 infection resulted in en-
hanced expression of an EndoH-sensitive form of MICA/B
(Fig. 4B) and HLA-I (Fig. 4C); HF consistently exhibit ex-
tremely low levels of constitutive MICA/B expression, which is
clearly upregulated upon Ad infection. Thus, mature EndoH-
resistant MICA/B forms of 
70 kDa were more readily de-
tected following infection with the HAdV-5 E3/19K mutants
FIG. 3. Deletion of E3/19K from Ad5 leads to an upregulation of cell surface MICA/B. (A) The wt HAdV-5 genome was cloned into a BAC,
and three E3/19K mutants were generated by recombineering as depicted. (B) Extracts from infected HF were harvested at 24 h p.i. and were
probed in a Western blot with anti-E3/19K MAb (Tw1.3) under nonreducing conditions and as a loading control with anti-phospho-S6-ribosomal
protein antibody to confirm deletion of the E3/19K gene. (C) HF infected with the indicated viruses at a multiplicity of infection of 3 were stained
at 48 h p.i. with anti-MICA/B, anti-MICA, or anti-MICB MAb before analysis by flow cytometry. The mouse IgG control is shown by the thin line,
and the filled histograms represent staining with anti-MICA/B, anti-MICA, or anti-MICB. The mean fluorescence intensity of the MAb staining
is depicted in the top right corners of the histograms. (D) HF infected at a multiplicity of infection of 3 with the indicated viruses at 48 h p.i. were
incubated for 6 h with IFN--activated PBMC cultures before being stained, and the number of CD107 NK (CD56 CD3	) cells was enumerated
by flow cytometry. Error bars indicate standard errors.
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(E3/19K and E3/19KSTOP) than in the uninfected controls
or in wt infection. The E3/19KW96A mutant was again asso-
ciated with an intermediate effect on MICA/B (Fig. 4B). Sam-
ples were immunoblotted for actin as a loading control (Fig.
4D). When expressed in continuous 293 cell lines or in the
context of productive Ad infection, E3/19K of species C Ads
(HAdV-2 and HAdV-5) acts to inhibit posttranslational mat-
uration of MICA and MICB.
The differential migration of deglycosylated MICA/B in the
two cell types can be attributed to allelic variation. While 293
cells are homozygous for the MICA*008 allele, HF carry full-
length alleles (MICA*016,*027). Further studies with the
FIG. 4. E3/19K inhibits posttranslational maturation of MICA/B. (A) Lysates from the 293 cell lines indicated were either mock digested
(M) or digested with EndoH (E) or PNGase F (P) before immunoblotting with a MICA/B-specific polyclonal antibody. Arrowheads denote
the mature EndoH-resistant forms, and arrows denote the EndoH-sensitive forms. (B) Lysates generated from HF cells infected at a
multiplicity of infection of 3 with the indicated viruses at 48 h p.i. were mock digested or digested with EndoH or PNGase F before
immunoblotting with a MICA/B-specific polyclonal antibody. Arrowheads denote the EndoH-resistant forms. (C) Lysates as described for
panel B were immunoblotted with anti-MHC-I monoclonal antibody (HC10). (D) Lysates as described for panel B were immunoblotted with
an antiactin antibody as a loading control.
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HAdV-5 E3/19K mutants in additional genotyped cell lines
(positive for MICA*004, MICA*018, and MICA*00901/*049)
have demonstrated that E3/19K was capable of acting on a
broad range of MICA alleles (data not shown).
Colocalization of E3/19K and MICA. To monitor the intra-
cellular localization of MICA during the course of an HAdV-5
infection, a plasmid encoding a MICA-YFP fusion protein was
transfected into 911 cells, where cell surface expression was
readily detected and confirmed by flow cytometry (not shown).
Following infection with HAdV-5 E3/19K, MICA-YFP re-
mained predominantly associated with the cell surface (Fig. 5,
top two rows). In contrast, in cells infected with wt HAdV-5
virus, the MICA-YFP fusion protein was found in distinct
intracellular foci that overlapped significantly with E3/19K
staining (Fig. 5, bottom two rows). These foci were found
within calnexin-labeled areas of the cell, consistent with the
E3/19K:MICA complex being retained within the ER. Indeed,
calnexin appears to be enriched in these foci. These foci do not
colocalize with any other intracellular compartment tested,
including endosomes, the Golgi apparatus, and caveolae (not
shown). The intracellular distribution of MICA-YFP following
HAdV-5 infection is consistent with E3/19K sequestration of
MICA/B in the ER.
DISCUSSION
E3/19K was shown to inhibit terminal glycosylation and to
downregulate cell surface expression of MHC-I more than 20
years ago (8). In addition to conferring protection against
MHC-I restricted cytotoxic T cells, we now show that the same
Ad gene product protects against NK cell attack by intracellu-
lar sequestration of the NK cell activating ligands MICA and
MICB. MICA/B downregulation from the cell surface was
demonstrated in continuous cell lines expressing HAdV-2 E3/
19K protein and with HAdV-5 E3/19K in the context of lytic
virus infection. All characterized human Ad serotypes in spe-
cies B, C, D, and E encode an E3/19K homolog (7). Suppres-
sion of both HLA-I and MICA/B requires both an ER reten-
tion/retrieval signal and formation of critical intramolecular
disulfide bonds; these features are conserved in E3/19K across
the different human Ad subtypes (11). Additional studies have
shown this NK cell evasion function is intact in HAdV-4 (spe-
cies E) (data not shown).
Although E3/19K and MICA/B colocalize, it has not yet
been demonstrated that the proteins interact directly. Hence,
the possibility that the interaction between E3/19K and MIC is
mediated by a cellular intermediate cannot formally be ruled
out. However, though quantitative phenotypic differences were
observed, virtually all cysteine E3/19K mutants exhibited a
simultaneous modulation of HLA-I, MICA, and MICB. The
E3/19K point mutant (W96A) provided some discrimination
by inducing suppression of MICA/B yet minimal downregula-
tion of HLA-I in continuous cell lines. Potentially, the trypto-
phan at position 96 may preferentially promote recognition of
HLA-I. This disparity was also observed, although it was less
pronounced, when the equivalent substitution was introduced
into the HAdV-5 genome. Further E3/19K mutagenesis will
show whether other amino acids are preferentially required for
HLA and MICA/B downregulation. In view of the limited
amino acid identity in the extracellular domains between MIC
and HLA alleles (
25%), it seems likely that E3/19K is rec-
ognizing a conserved structure in these molecules. In this con-
text, it is remarkable that E3/19K can accommodate the ex-
treme polymorphism associated with HLA-I, MICA, and
MICB.
MICA and MICB are cell surface glycoproteins with MHC-
I-like 1, 2, and 3 domains, yet neither associates with
2-microglobulin or presents peptide (23). We have previously
shown that E3/19K can bind MHC-I heavy chains in the ab-
sence of 2-microglobulin and prior to folding of the 1 and 2
domains (34, 41). E3/19K recognition of HLA-I also proceeds
independently of peptide binding in vitro (34). Thus, E3/19K
appears to bind at an early stage during the assembly of MHC-
I-like proteins, presumably at the level of calnexin interaction.
In this study, we used calnexin as an ER marker together with
a MICA-YFP fusion protein to help identify the intracellular
site of MICA retention. The MICA-YFP and E3/19K were
observed to colocalize with calnexin in bright foci within the
cells. In most cell types E3/19K exhibits a reticular ER-like
staining rather than a focal distribution, and the concentration
of complexes into foci may be a consequence of MICA-YFP
overexpression. Nevertheless, the association of calnexin with
these foci is consistent with ER retention.
Human cytomegalovirus (HCMV) encodes a number of
functions that modulate NK cell recognition (16, 46, 47), in-
cluding at least three genes that specifically target NKG2DLs.
UL142 downregulates MICA alleles but not the truncated
MICA*008 allele, and it does not affect MICB (13). UL16
encodes an ER-localized glycoprotein that acts to promote
intracellular retention of MICB, ULBP1, and ULBP2 (16). In
FIG. 5. MICA and E3/19K colocalize in the ER. 911 cells stably
expressing a MICA-YFP fusion protein were infected at a multiplicity
of infection of 5 with wt HAdV-5 or E3/19K for 24 h. E3/19K-
infected cells were stained with an antibody cocktail against E1A or
calnexin, and wt HAdV-5-infected cells were stained with anti-E3/19K
or anticalnexin. The nuclei were counterstained with DAPI (4,6-
diamidino-2-phenylindole). Antibody staining is in red, and the MICA-
YFP fusion protein fluorescence is depicted in green.
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addition, a recent report indicates that an HCMV-encoded
micro-RNA specifically targets the 3 untranslated region of
the MICB transcript (43). Although E3/19K and HCMV
gpUL16 both promote ER retention and accumulation of
NKG2DLs, their functions are quite distinct. E3/19K targets
both MICA and MICB with similar efficiency and does not
affect ULBP1 to -3 (data not shown), whereas UL16 does not
target MICA or HLA-I. E3/19K thus has a novel function in
being able to target a broad range of MICA and MICB alleles;
in particular, it can target the MICA*008 allele, which is the
most commonly expressed allele in populations studied to date
(35, 38). It has been speculated that the MICA*008 allele may
have emerged as a result of the host response to viral evasion
functions acting on MICA (53). However, E3/19K can clearly
retain both full-length and truncated MICA alleles and thus rep-
resents the first description of a viral protein that can downregu-
late surface expression of the commonly expressed MICA*008
allele.
The identification of this novel function for E3/19K has
implications for the design and application of Ad vector sys-
tems (replication deficient and replication competent) and
therapeutic oncolytic viruses. Murine models are used exten-
sively to evaluate Ad vectors and oncolytic viruses in vivo.
While a comparable murine NKG2D receptor exists, the
NKG2DLs have diverged so there is no direct equivalent of
MICA and MICB. It should therefore be borne in mind that
the E3/19K-mediated NK cell evasion function described here
would not be expected to operate in mice. NKG2D also acts as
a costimulatory molecule for  CD8 T cells (3), and E3/19K
expression has been shown to protect infected cells from cyto-
toxic T-lymphocyte attack (1, 10, 21). Previously this was at-
tributed solely to its ability to downregulate surface MHC-I,
but the intracellular retention of potential costimulatory li-
gands by E3/19K can be expected to contribute to this effect.
NKG2D is expressed on additional important immune effector
cells, including  T cells and IFN-producing killer dendritic
cells (3, 14). Thus, the inhibition of NKG2DL surface expres-
sion by E3/19K is expected to affect the recognition of Ad-
infected cells by multiple effector cells of both the innate and
adaptive immune systems.
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